Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Cholesterol Test market is witnessing a significant trend driven by the rising prevalence of cardiovascular diseases globally. With heart-related conditions on the rise, there is a growing demand for cholesterol tests as a crucial diagnostic tool. This trend reflects the increasing awareness of the link between cholesterol levels and cardiovascular health.
A big change in the market is more people using home cholesterol tests. This change lets for fast and easy testing in different health care places, such as clinics and drugstores. Point-of-care tests give quick answers. This lets for fast action and tailored handling of cholesterol levels, helping patients do better overall.
Technology is always changing, and this affects how we do cholesterol tests. New ways to test things, like improved fat measuring and non-harmful methods are becoming popular. These tech improvements make cholesterol tests more accurate and dependable. This helps doctors get better information for finding out what's wrong and making treatment plans.
People are paying more attention to stopping health problems before they happen, and this is affecting the market. They're becoming active about checking their cholesterol levels from time to time. By understanding how cholesterol affects heart health better, more people have been getting tests done. So the market for these tests is growing bigger.
Digital health tools are very important in the cholesterol test market. People are using more and more phone apps or wearable things to monitor cholesterol levels. These combined solutions let people watch their health all the time, making it an ongoing and personal way to control cholesterol levels.
A big change is that more people are using tests for cholesterol at home. These kits let them check their own levels of cholesterol easily without going to a doctor's office or lab. Easy-to-use kits have made cholesterol testing more available, encouraging regular checking and early warning of potential health issues. This pattern matches the increasing choice for care at home.
The market for cholesterol tests is changing towards personal care, where information from the test results is used to make specific treatment plans. Health workers are more and more using personal cholesterol information to make specific plans. These include changing daily habits and medicine rules, depending on a person's needs. This special way makes taking care of cholesterol better.
Together, healthcare workers and companies that make tests are changing the picture of how things work in this market. Partners want to make checking cholesterol easy in everyday health care. These teams help to make rules for cholesterol tests, making sure they are always good and same in all healthcare places.
Regulatory groups are focusing more on how well and right cholesterol tests are done. Strict rules help develop and sell cholesterol testing items, making sure they are very reliable. This focus on rules helps build trust in cholesterol test results for both doctors and patients.
The cholesterol test market is expanding globally, with efforts to increase access to testing in various regions. This expansion is crucial for addressing disparities in healthcare access and ensuring that individuals worldwide have the opportunity to undergo cholesterol testing. The trend towards global outreach aligns with the broader goal of improving cardiovascular health on a global scale.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Opportunities | High growth potential in emerging economies. |
| Market Dynamics | Increasing incidence of cardiovascular diseases and obesity Physician’s preference for lab testing over self-testing |
Cholesterol Test Market Highlights:
Global Cholesterol Test Market Overview
The cholesterol test market size was valued at USD 6.2 billion in 2022 and is projected to grow from USD 6.7 Billion in 2023 to USD 11.77 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.3% during the forecast period (2023 - 2032). The growing prevalence of high cholesterol levels is expected to drive the growth. Rising awareness about a routine screening of cholesterol levels is another significant growth driver. These are just a few of the market drivers that are driving the market.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Cholesterol Test Market Trends
- Prevalence of cardiovascular diseases and rising cases of obesity propel market growth
The prevalence of cardiovascular diseases and rising cases of obesity are significantly driving market growth. Moreover, the inelastic need is related to cardiovascular patients requiring daily monitoring of Cholesterol for effective therapeutic monitoring. The health departments of various countries stipulate that children aged 9-11 should be tested, and young adults aged 17-21 should be tested. Cholesterol testing is critical to keeping patients on track with their health, as high Cholesterol shows no symptoms. Cholesterol testing involves estimating different lipids, such as triglycerides, HDL, LDL, and total blood cholesterol. If performed effectively with proper precautions at each stage, these tests can help reduce the risk of heart attack, peripheral arterial disease, and heart disease. Thus, this factor is driving the market CAGR.
Increasing numbers of heart attacks, diabetes, kidney failure and heart attacks have affected millions worldwide. Rising R&D investments and the development of new advanced testing procedures, supported by technological advancements in healthcare infrastructure in developing countries, have increased the demand for these tests. Advances in healthcare infrastructure have facilitated a high level of efficiency in diagnostic and Cholesterol management procedures. Furthermore, the rising adoption of AI and IoT in healthcare helps boost the market over the forecast period. Thus, it is anticipated that this aspect will accelerate the Cholesterol Test market revenue globally.
Cholesterol Test Market Segment Insights
Cholesterol Test Product Type Insights
Based on product type, the market segments of cholesterol test includes test kits and test strips. The test kits held the majority share in 2022 in the Cholesterol Test market data. Patients now have better access to cholesterol testing thanks to the development of cutting-edge testing kits. Due to technological advancements, cholesterol testing kits are expected to be the fastest-growing segment.
Cholesterol Test Test Type Insights
Based on test type, the Cholesterol Test market segmentation includes total cholesterol test, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) and Cholesterol and triglycerides/VLDL cholesterol test. The total cholesterol test dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2023-2032. This is attributed to an increased awareness of routine cholesterol testing and treatment and the sedentary lifestyle that contributes to the development of many diseases, including diabetes, which drives the market's growth.
Cholesterol Test Distribution Channel Insights
The market data of cholesterol test, based on the distribution channel, include over-the-counter and Prescription based. The target audience prefers all these distribution channels according to the consumer's requirements.
Cholesterol Test End-User Insights
Based on end-user, the market data of Cholesterol Test include hospitals & clinics, home care and diagnostic centers. The diagnostic center segment dominated the market revenue of Cholesterol Test in 2022 and is projected to be the faster-growing segment during the forecast period 2023-2032. Since more and more people are being diagnosed with high total Cholesterol, the demand for the market is rising. Moreover, regular health check-ups without physician intervention are a high-impact driver for the segment's growth.
Figure 1 Cholesterol Test Market by End-User, 2022 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Cholesterol Test Regional Insights
By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North America Cholesterol Test market accounted for USD 2.8 billion in 2022, with a share of around 45.80%, and is expected to exhibit a significant CAGR growth during the study period. Americas is the most important regional market. Countries like the US have well-developed healthcare operations. Furthermore, one of the major reasons driving the cholesterol testing market during the forecast years is the rising prevalence of stroke in the United States.
Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2 CHOLESTEROL TEST MARKET SHARE BY REGION 2022 (%)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's Cholesterol Test market accounts for the second-largest market share. Rising awareness among patients regarding preventive healthcare has increased the usage of cholesterol-testing products and services. Potential players in the market have helped increase market efficiency and production of these test kits and devices, further increasing the market opportunity. Moreover, the UK market of cholesterol test held the largest market share, and the Germany market of cholesterol test was the fastest-growing market in the region.
Asia Pacific Cholesterol Test Market is expected to grow at the fastest CAGR from 2023 to 2032. Asia Pacific is growing faster and more lucrative owing to the increasing population in the region. An increase in investment and expenditure in healthcare infrastructure has led to the development of diagnostic centers and pathology laboratories for better diagnosis. Further, the China market of cholesterol test held the largest market share, and the India market of cholesterol test was the fastest-growing market in the region.
Cholesterol Test Key Market Players & Competitive Insights
Major market players are spending a lot on R&D to increase their product lines, which will help the market of Cholesterol Test grow even more. Market participants are also taking various strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the Cholesterol Test industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies manufacturers adopt in the Cholesterol Test industry to benefit clients and expand the market sector is manufacturing locally to reduce operating costs. The Cholesterol Test industry has provided medicine with some of the most significant benefits in recent years. The Cholesterol Test market players such as Nestle, JM Smucker Company, The Kraft Heinz Company and Starbucks Cholesterol Test Company.
Quest Diagnostics empowers people to take action to improve health outcomes. Quest's diagnostic insights, drawn from the world's largest database of clinical laboratory results, reveal new ways to identify and treat disease, inspire healthy behaviors, and improve healthcare management. In June 2022, Quest Diagnostics, the world's leading provider of diagnostic information services, announced that it would hold its 82nd. The results of six studies were presented at the American Diabetes Association Scientific Sessions in New Orleans, LA.
Also, Thermo Fisher Scientific Inc. is an American provider of scientific instruments, reagents and consumables, and software services. Thermo Fisher, headquartered in Waltham, Massachusetts, was formed in 2006 through the merger of Thermo Electron and Fisher Scientific. Thermo Fisher Scientific has acquired other reagents, consumables, instrumentation and service providers, including Life Technologies Corporation (2013), Affymetrix (2015), Affymetrix (2016), FEI Corporation (2016), BD Advanced Bioprocessing (2018), PPD (2021).
Key Companies in the market of Cholesterol Test include
- Quest Diagnostics Incorporated
- Clinical Reference Laboratory Inc.
- Randox Laboratories Ltd.
- PTS DIAGNOSTICS
- Hoffmann-La Roche AG
- Cell Biolabs Inc.
- Laboratory Corporation of America Holdings
- Thermo Fisher Scientific
- Alere Inc.
- Eurofins Scientific
Cholesterol Test Industry Developments
May 2022 Goodbody Health launched its core UK Health 'MOT' test. This new Test includes innovative clinical diabetes and cholesterol tests that can confirm results in minutes. These tests determine a person's risk of developing heart health problems or diabetes over the next ten years.
March 2022 Rosalind Franklin University's (RFU) Community Nursing Connection and a new partnership with North Shore University Health System continue to provide life-saving medical care to the underserved in many North Chicago communities. Care Coach, a mobile health unit staffed by licensed healthcare professionals, will directly benefit from $680,000 in financing from the NorthShore Community Investment Fund (CIF). The mobile device provides blood pressure control, diabetes screening, BMI, cholesterol testing and other free health treatments.
Cholesterol Test Market Segmentation
Cholesterol Test Product Type Outlook (USD Billion, 2018-2030)
- Test Kits
- Test Strips
Cholesterol Test Test Type Outlook (USD Billion, 2018-2030)
- Total Cholesterol Test
- High-Density Lipoprotein (HDL) Cholesterol
- Low-Density Lipoprotein (LDL)
- Cholesterol and Triglycerides/VLDL Cholesterol Test)
Cholesterol Test Distribution Channel Outlook (USD Billion, 2018-2030)
- Over the Counter
- Prescription Based
Cholesterol Test End-User Outlook (USD Billion, 2018-2030)
- Hospitals & Clinics
- Homecare
- Diagnostic Centers
Cholesterol Test Regional Outlook (USD Billion, 2018-2030)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- AfricaLatin America
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
